Bioadhesive and formulation parameters affecting nasal absorption

International Journal of Pharmaceutics

Volumn 127, Issue 2, 1996, Pages 115-133

  Dondeti, Polireddy ^a   Zia, Hossein ^a   Needham, Thomas E ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOIC ACID; BETA INTERFERON; CALCITONIN; DESMOPRESSIN; DOPAMINE; DRUG CARRIER; GENTAMICIN; HUMAN GROWTH HORMONE; HYALURONIC ACID; INSULIN; METHYLCELLULOSE; NIFEDIPINE; PENETRATION ENHANCING AGENT; POLYMER; PROPRANOLOL; VASOPRESSIN;

ADHESION; DOG; DRUG ABSORPTION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG RELEASE; GEL; INTRANASAL DRUG ADMINISTRATION; MUCOCILIARY CLEARANCE; NONHUMAN; NOSE; OSMOLARITY; PARTICLE SIZE; PH; PRIORITY JOURNAL; RAT; REVIEW; VISCOSITY;

EID: 0029881341     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04115-X     Document Type: Review

References (98)

1. 99m instilled intranasally. Br. J. Clin. Pharm., 3 (1976) 869-878.
2. Audhya, T. and Goldstein, G., Comparative efficacy of various routes of administration of thymopentin (TP-5) with consideration of degradative mechanisms. Int. J. Peptide Protein Res., 22 (1983) 187-193.
3. Bremecker, K.D., In Gurny, R. and Junginger, H.E., (Eds.), Bioadhesion, Possibilities and Future Trends, Paperback APV Band 25, Wissenschaftliche VerlagsgellschaftmbH, Stuttgart, 1990, pp. 191-201.
4. Bjork, E. and Edman, P., Degradable starch microspheres as a nasal delivery system for insulin. Int. J. Pharm., 47 (1988) 233-236.
5. Bodde, H.E., De Vries, M.E. and Junginger, H.E., Mucoadhesive polymers for the buccal delivery of peptides: structure-adhesiveness relationships. J. Controlled Release, 13 (1990) 225-231.
6. Bond, S.W., Hardy, J.G. and Wilson, C.G., Deposition and clearance of nasal sprays. Proceedings of the 2nd European Congress of Biopharmaceutics and Pharmacokinetics, Salamanca, 1 (1984) 93-98.
7. Chen, J.L. and Cyr, G.N., Compositions producing adhesion through hydration. In Manly, R.S. (Ed.), Adhesive Biological System, Academic Press, New York (1970) Chapter 10.
8. Chien, Y.W., Su, K.S.E, and Chang, S.F. (Eds.), Nasal Systemic Drug Delivery, Dekker, New York (1989).
9. Chu, J.S., Chandrasekharan, R., Amidon, G.L., Weiner, N.D. and Goldberg, A.H., Viscometric study of polyacrylic acid systems as mucoadhesive sustained-release gels. Pharm. Res., 8 (1991) 1408-1412.
10. Corbo, D.C., Huang, Y.C. and Chien, Y.W., Nasal delivery of progestational steroids in ovariectomized rabbits. I. Progesterone - comparison of pharmacokinetics with intravenous and oral administration, Int. J. Pharm., 46 (1988) 133-140.
11. Corbo, D.C., Liu, J.C. and Chien, Y.W., Characterization of the barrier properties of mucosal membranes. J. Pharm. Sci., 79 (1990) 202-206.
12. Critchley, H., Davis, S.S., Farraj, N.F. and Illum, L., Nasal absorption of desmopressin in rats and sheep: effect of a bioadhesive microsphere delivery system. J. Pharm. Pharmacol., 46 (1994) 651-656.
13. Dalton, M.E., Bromham, D.R., Ambrose, C.L., Osborne, J. and Dalton, K.D., Nasal absorption of progesterone in women. Br. J. Obstet. Gynecol., 94(1) (1987) 84-88.
14. Debenedetti, P.G., Tom, J.W., Yeo, S.D. and Lim, G., Application of supercritical fluids for the production of sustained delivery devices. J. Controlled Release, 24 (1993) 27-44.
15. Dondeti, P., Zia, H., Needham, T.E. and Luzzi, L.A., Development of a new non-surgical perfusion technique to evaluate nasal drug delivery. Pharmazie, 49 (1994a) 505-509.
16. Dondeti, P., Optimization of Nasal Delivery of Insulin. Ph.D. Dissertation, University of Rhode Island, Kingston, RI (1994b).
17. Dondeti, P., Zia, H. and Needham, T.E., In-vivo evaluation of spray formulations of human insulin for nasal delivery. Int. J. Pharm. Accepted for publication (February 1st, 1995).
18. Donovan, M.D., Flynn, G.L. and Amidon, G.L. Absorption of polyethylene glycols 600 through 2000: the molecular weight dependence of gastrointestinal and nasal absorption, Pharm. Res., 7 (1990) 863-868.
19. Duchene, D., Touchard, F. and Peppas, N.A., Pharmaceutical and medical aspects of bioadhesive systems for drug administration, Drug Dev. Ind. Pharm., 14 (1988) 283-318.
20. Duchene, D. and Ponchel, G., Principle and investigation of the bioadhesion mechanism of solid dosage forms. Biomaterials, 13 (1992) 709-713.
21. Duchene, D. and Ponchel, G., Nasal administration: a tool for tomorrow's systemic administration of drugs, Drug Dev. Ind. Pharm., 19 (1993) 101-122.
22. Edman, P. and Bjork, E., Routes of delivery: case studies -nasal delivery of peptide drugs. Adv. Drug Del. Rev., 8 (1992) 165-177.
23. Edman, P., Bjork, E. and Ryden, L., Microspheres as a nasal delivery system for peptide drugs. J. Controlled Release, 21 (1992) 165-172.
24. Farraj, N.F., Johansen, B.R., Davis, S.S., and Illum, L., Nasal administration of insulin using bioadhesive microspheres as a delivery system. J. Controlled Release, 13 (1990) 253-261.
25. Fisher, A.N., Brown, K., Davis, S.S., Parr, G.D., and Smith, D. F., The effect of molecular size on the nasal absorption of water soluble compounds in the albino rat. J. Pharm. Pharmacol., 39 (1987) 357-362.
26. Gonda, I. and Gipps, E., Model of disposition of drugs administered into the human nasal cavity. Pharm. Res., 7 (1990) 69-75.
27. Gu, J.M., Robinson, J.R. and Leung, S.S., Binding of acrylic polymers to mucin/epithelial surfaces: structure-property relationships. Crit. Rev. Ther. Drug Carrier Systems, 5 (1988) 21-67.
28. Gurny, R., Meyer, J.M. and Peppas, N.A., Bioadhesive intraoral release systems: design, testing and analysis. Biomaterials, 5 (1984) 336-340.
29. Hardy, J.G., Lee, S.W. and Wilson, C.G., Intranasal drug delivery by spray and drops. J. Pharm. Phrmacol., 37 (1985) 294-297.
30. Harris, A.S., Nilsson, I.M., Wagner, Z.G., and Alkner, U., Intranasal administration of peptides: nasal deposition, biological response and absorption of desmopressin. J. Pharm. Sci., 75 (1986) 1085-1088.
31. Harris, A.S., Ohlin, M., Svensson, E., Lethagen, S. and Nilsson, I.M., Effects of concentration and volume on nasal bioavailability and biological response to desmopressin. J. Pharm. Sci., 77 (1988a) 337-339.
32. Harris, A.S., Svensson, E., Wagner, Z.G., Lethagen, D. and Nilsson, I.M., Effect of viscosity on particle size, deposition and clearance of nasal delivery systems containing desmopressin. J. Pharm. Sci., 77 (1988b) 405-408.
33. Harris, A.S., Ohlin, M., Svensson, E., Lethagen, S. and Nilsson, I.M., Effect of viscosity on the pharmacokinetics and biological response to intranasal desmopressin. J. Pharm. Sci., 78 (1989) 470-471.
34. Harris, D. and Robinson, J.R Bioadhesive polymers in peptide drug delivery. Biomaterials, 11 (1990) 652-658.
35. Hirai, S., Ikenaga, T. and Matsuzawa, T. Nasal absorption of insulin in dogs. Diabetes, 27 (1978) 296-299.
36. Hoffman, A.S., Afrassiabi, A. and Dong, L.C., Thermally reversible hydrogels II: Delivery and selective removal of substances from aqueous solutions. J. Controlled Release, 4 (1986) 213-222.
37. Huang, C.H., Kimura, R., Bawarshi-Nassar, R. and Hussain, A., Mechanism of nasal absorption of drugs I: Physicochemical parameters influencing the rate of in situ nasal absorption of drugs in rats. J. Pharm. Sci., 74 (1985a) 608-611.
38. Huang, C.H., Kimura, R., Bawarshi-Nassar, R. and Hussain, A., Mechanism of nasal absorption of drugs II: Absorption of tyrosine and the effect of structural modification on its absorption, J. Pharm. Sci., 74 (1985b) 1298-1300.
39. Hughes, B.L., Allen, D.L., Dorato, M.A. and Wolff, R.K., Effect of delivery devices on nasal deposition and mucociliary clearance in rhesus monkeys. Aerosol Sci. Tech., 18 (1993) 241-249.
40. Hussain, A., Hirai, S. and Bawarshi, R., Nasal absorption of propranolol from different dosage forms by rats and dogs, J. Pharm. Sci., 69 (1980) 1411-1413.
41. Hussain, A.A., Bawarshi-Nassar, R. and Huang, C.H., Physicochemical considerations in intranasal drug administra-tions. In Chien Y.W. (Ed.), Transnasal Systemic Medications, Elsevier, Amsterdam (1985) 121-137.
42. Ikeda, K., Murata, K., Kobayashi, M. and Noda K., Enhancement of bioavailability of dopamine via nasal route in beagle dogs. Chem. Pharm. Bull., 40 (1992) 2155-2158.
43. Illum, L., Jorgensen, H., Bisgaard, H., Krogsgaard, O. and Rossing, N., Bioadhesive microspheres as a potential nasal drug delivery system. Int. J. Pharm., 39 (1987) 189-199.
44. Illum, L., Farraj, N.F., Critchley, H. and Davis, S.S., Nasal administration of gentamicin using a novel microsphere delivery system. Int. J. Pharm., 46 (1988) 261-265.
45. Illum, L., Farraj, N.F., Davis, S.S., Johansen, B.R., and O'Hagan, D.T., Investigation of the nasal absorption of biosynthetic human growth hormone in sheep - use of a bioadhesive microsphere delivery system. Int. J. Pharm., 63 (1990) 207.
46. Illum, L., Farraj, N.F., Davis, S.S., Chitosan as a novel nasal delivery system for peptide drugs. Pharm. Res., 11 (1994) 1186-1189.
47. Jimenez-Castellanos, M.R., Zia, H. and Rhodes, C.T., Mucoadhesive drug delivery systems. Drug Dev. Ind. Pharm., 19 (1993) 143-194.
48. Juhasz, J., Lenaerts, V. and Ong, H., Poloxamer gels for peptide delivery - in vitro studies. J. Controlled Release, 13 (1990) 322.
49. K̇oochaki, P.E., Nasal pharmaceutical composition in powder form. European Patent Application EP 571671 (1993).
50. Lee, V.H.L., Yamamoto, A. and Kompella, U.B. Mucosal penetration enhancers for facilitation of peptide and protein drug absorption. Crit. Rev. Ther. Drug Carrier Systems, 8 (1991) 91-192.
51. Lee, W.A. and Longenecker, J.P., Intranasal delivery of proteins and peptides. BioPharm, 1 (1988) 30-37.
52. Lee, W.A., Permeation enhancers for the nasal delivery of protein and peptide therapeutics. BioPharm , 3 (1990) 22-25.
53. Leung, S.H.S. and Robinson, J.R., The contribution of anionic polymer structural features to mucoadhesion, J. Controlled Release, 5 (1988) 223-226.
54. Leung, S.H.S. and Robinson, J.R., Bioadhesives in drug delivery. Polymer News, 15 (1990) 333-342.
55. Leung, S.S., Nagai, T. and Machida, Y., Mucoadhesive dosage forms for peptide and protein drug delivery. In Peptide and Protein Drug Delivery, Marcel Dekker, Inc., New York (1992) 741-768.
56. Lewis, H.J., and Kellaway, I.W., In-vitro investigation of the potential of mucoadhesive microspheres for the controlled nasal delivery of oxytocin. J. Pharm. Pharmacol., 42 (Suppl.) (1990) 142P.
57. Lin, S.Y., Yu, D.M.S. and Amidon, G.L., Intranasal gelling delivery systems: a viscoelasticity analysis of nasal residence time. Pharm. Res., 10 (1993) S-195.
58. Luk, C.K. and Dulfano, M.J., Effect of pH, viscosity and ionic strength changes on ciliary beat frequency of human bronchial explants. Clin. Sci., 64 (1983) 449-451.
59. Machida, M., Sano, K., Arakawa, M., Hayashi, M. and Awazu, S., Absorption of recombinant human granulocyte colony-stimulating fatcor (rhG-CSF) from rat nasal mucosa. Pharm. Res., 10 (1993) 1372-1377.
60. Maitani, Y., Machida, Y. and Nagai, T., Influence of molecular weight and charge on nasal absorption of dextran and DEAE-dextran in rabbits. Int. J. Pharm., 49 (1989a) 23-27.
61. Maitani, Y., Igawa, T., Machida Y., and Nagai, T., Plasma levels following intranasal and intravenous administration of human Interferon-β to rabbits. Drug Des. Del., 4 (1989b) 109-119.
62. Merkus, F.W.H.M., Schipper, N.G.M., Hermens, W.A.J.J., Romeijn, S.G. and Verhoef J.C., Absorption enhancers in nasal drug delivery: efficacy and safety. J. Controlled Release, 24 (1993) 201-208.
63. McMartin, C., Hutchinson, L.E.F., Hyde, R. and Peters, G.E., Analysis of structural requirements for the absorption of drugs and macromolecules from the nasal cavity, J. Pharm. Sci., 76 (1987) 535-540.
64. Mikos, A.G. and Peppas N.A., Scaling concepts and molecular theories of adhesion of synthetic polymers to glycoproteinic networks. In Lenaerts, V. and Gurny, R. (Eds.), Bioadhesive Drug Delivery Systems, CRC Press, Inc., Boca Raton, FL (1990) 25-42.
65. Morimoto, M., Morisaka, K. and Kamada, A., Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel. J. Pharm. Pharmacol., 37 (1985) 134-136.
66. Morimoto, K., Tabata, H. and Morisaka, K., Nasal absorption of nifedipine from gel preparations in rats. Chem. Pharm. Bull., 35 (1987) 3041-3044.
67. Morimoto, K., Yamaguchi, H., Iwakura, Y., Morisaka, K., Ohashi, Y. and Nakai, Y., Effects of viscous hyaluronatesodium solutions on the nasal absorption of vasopressin and an analogue. Pharm. Res., 8 (1991) 471-474.
68. Mygind, N. Nasal Allergy, 2nd Edition, Alden Press, Oxford (1979) 257-270.
69. Nagai, T., Nishimoto, Y., Nambu, N., Suzuki, Y., and Sekine, K., Powder dosage form of insulin for nasal administration. J. Controlled Release, 1 (1984) 15-22.
70. Nagai, T., and Machida, Y., Bioadhesive dosage forms for nasal administration. In Lenaerts, V. and Gurny, R. (Eds.), Bioadhesive Drug Delivery Systems, CRC Press, Inc., Boca Raton, FL (1990) 169-178.
71. Newman, S.P., Moren, F. and Clarke, S.W., Deposition pattern from a nasal pump spray. Rhinology, 25 (1987) 77-82.
72. Newman, S.P., Steed, K.P., Hardy, J.G., Wilding, I.R., Hooper, G. and Sparrow, R.A., The distribution of an intranasal insulin formulation in healthy volunteers: effect of different administration techniques. J. Pharm. Phrmacol., 46 (1994) 657-660.
73. Ohwaki, T., Ando, H., Watanabe, S., and Miyake, Y., Effects of dose, pH and osmolarity on nasal absorption of secretin in rats. J. Pharm. Sci., 74 (1985) 50-52.
74. Ohwaki, T, Ando, H., Kakimoto, F., Uesugi, K., Watanabe, S., Miyake, Y. and Kayano, M., Effects of dose, pH and osmolarity on nasal absorption of secretin in rats II: Histological aspects of the nasal mucosa in relation to the absorption variation due to the effects of pH and osmolarity. J. Pharm. Sci., 76 (1987) 695-698.
75. Park, H. and Robinson, J.R., Physico-chemical properties of water insoluble polymers important to mucin/epithelial adhesion. J. Controlled Release, 2 (1985) 45-57.
76. Park, H. and Robinson, J.R., Mechanisms of mucoadhesion of polyacrylic acid hydrogels. Pharm. Res., 4 (1987) 457-464.
77. Park, K., Ch'ng, H.S., and Robinson, J.R., Alternative approaches to oral controlled drug delivery: Bioadhesives and in-situ systems. In Anderson, J.M. and Kim, S.W. (Eds.), Recent Advances in Drug Delivery Systems, Plenum Press. (1984) 163.
78. Park, K and Park, H., Test methods of bioadhesion. In Lenaerts, V. and Gurny, R. (Eds.), Bioadhesive Drug Delivery Systems, CRC Press, Inc., Boca Raton, FL (1990) 43-64.
79. Pennington, A.K., Ratcliffe, J.H., Wilson, CG. and Hardy, J.G., The influence of solution viscosity on nasal spray deposition and clearance. Int. J. Pharm., 43 (1988) 221-224.
80. Peppas, N.A. and Reinhart, C.T., Solute diffusion in swollen membranes. Part I. A new theory. J. Membr. Sci., 15 (1983) 275-278.
81. Peppas, N.A., Surface, interfacial and molecular aspects of polymer bioadhesion on soft tissues. J. Controlled Release, 2 (1985) 257-275.
82. Popovici, A. and Szasz, I., Mucoadhesive gel with polyuranides for endonasal administration. In Duchene, D. (Ed.), Minutes European Symposium "Buccal and Nasal Administration as an Alternative to Parenteral Administration", Editions de Sante, Paris (1992) 292-296.
83. Pujara, C., Shao, Z., Duncan, M.R. and Mitra, A.K., Effects of formulation variables on nasal epithelial cell integrity: biochemical evaluations. Int. J. Pharm., 114 (1995) 197-203.
84. Ryden, L. and Edman, P., Effect of polymers and microspheres on nasal absorption of insulin in rats. Int. J. Pharm., 83 (1992) 1-10.
85. Schipper, N.G.M., Verhoef J.C. and Merkus, F.W.H.M., The nasal mucociliary clearance: relevance to nasal drug delivery, Pharm. Res., 8 (1991) 807-814.
86. Schipper, N.G.M., Romeijn, S.G., Verhoef, J.C. and Merkus, F.W.H.M., Nasal insulin delivery with dimethyl-β-cyclodextrin as an absorption enhancer in rabbits: powder more effective than liquid formulations. Pharm. Res., 10 (1993) 682-686.
87. Smart, J.D., Kellaway, I.W. and Worthington, H.E.C., An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. J. Pharm. Phrmacol., 36 (1984) 295.
88. Smith, R.L., Smyth, R.E., Keck, B.D., Kinnett, G.O. and Cruze, C.A., Effect of formulation and dosing variables on the intranasal absorption of loperamide in the rat. Pharm. Res., 9 (1992) S-207.
89. Su, K.S.E. and Campanale, K.M., Nasal delivery of insulin: biopharmaceutical aspects and animal model choice. Pharm. Res., 5 (1988) S-96.
90. Su, K.S.E., Nasal route of peptide and protein drug delivery. In Lee, V.H.L. (Ed.), Peptide and Protein Drug Delivery, Marcel Dekker, Inc., New York (1992) 595-632.
91. Su, K.S.E., Intranasal Drug Delivery. In Swarbrick, J. and Boylan, J.C. (Eds.), Encyclopedia of Pharmaceutical Sciences. Marcel Dekker, Inc., New York, 8 (1993) 175-201.
92. Tom, J.W., Lim, G., Debenedetti, P.G. and Prud'homme, R.K., Applications of supercritical fluids in the controlled release of drugs. In 'Supercritical Fluid Engineering Science-Fundamentals and Applications', Kiran, E. and Brennecke, J.F., ACS Symposium Series 514 (1993) Chapter 19, Washington, DC.
93. Uchida, N., Maitani, Y., Machida, Y., Nakagaki, M. and Nagai, T., Influence of bile salts on the permeability of insulin through the nasal mucosa of rabbits in comparison with dextran derivatives. Int. J. Pharm., 74 (1991) 95-103.
94. Van de Donk, H.J.M., Zuidema, J. and Merkus, F.W.H.M., The influence of the pH and osmotic pressure upon tracheal ciliary beat frequency as determined with a new photoelectric registration device. Rhinology, 18 (1980) 93-104.
95. Vyas, S.P., Bhatnagar, S., Gogoi, P.J. and Jain, N.K., Preparation and characterization of HSA-propranolol microspheres for nasal administration. Int. J. Pharm., 69 (1991) 5-12.
96. Xi, N.Z., Jiang, X.G., Wang, X.J. and Zhu, F.H., Nasal absorption of piroxicam in humans from gel preparation. In Duchene, D. (Ed.), Minutes European Symposium "Bucal and Nasal Administration as an Alternative to Parenteral Administration", Editions de Sante, Paris (1992) 303-307.
97. Zia, H., Dondeti, P. and Needham, T.E., Nasal drug delivery. Clin. Res. Regul. Aff., 10 (1993a) 99-135.
98. Zia, H., Needham, T.E. and Luzzi, L.A., Why infusion and not microcapsules or other controlled release methods? In Karsa, D.R. and Stephenson, R.A. (Eds.), Encapsulation and Controlled Release, Royal Society of Chemistry, (1993b) 117-130.